No abstract available
Publication types
-
Clinical Trial, Phase I
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Carbamates / adverse effects
-
Carbamates / therapeutic use*
-
Female
-
Humans
-
Janus Kinase 2 / genetics
-
Male
-
Maximum Tolerated Dose
-
Middle Aged
-
Mutation
-
Polycythemia Vera / drug therapy*
-
Polycythemia Vera / genetics
-
Polycythemia Vera / psychology
-
Quality of Life
Substances
-
Carbamates
-
givinostat
-
JAK2 protein, human
-
Janus Kinase 2